What is Ground Zero Pharmaceuticals?
Ground Zero Pharmaceuticals, Inc. (GZP) is dedicated to advancing medical product programs through the rigorous FDA regulatory pathway, from late-stage discovery to post-approval. The company's operational philosophy centers on executing necessary and sufficient development steps, thereby enabling clients to benefit from streamlined, cost-effective, and accelerated development plans. GZP's emphasis on rapid and resource-efficient completion of each product lifecycle phase, while upholding quality standards for FDA review, adds substantial value by facilitating the achievement of critical milestones.
How much funding has Ground Zero Pharmaceuticals raised?
Ground Zero Pharmaceuticals has raised a total of $344K across 2 funding rounds:
Debt
$150K
Debt
$194K
Debt (2020): $150K with participation from PPP
Debt (2021): $194K led by PPP
What's next for Ground Zero Pharmaceuticals?
With the recent strategic investment and substantial total funding, Ground Zero Pharmaceuticals is well-positioned for its next phase of growth. This capital is expected to fuel the acceleration of its product development pipeline and potentially expand its regulatory support services. The company's focus on efficient and targeted development plans suggests a strategy aimed at achieving key regulatory approvals and market entries in the near future, further solidifying its role as a key player in pharmaceutical development.
See full Ground Zero Pharmaceuticals company page
